Works matching IS 00071188 AND DT 2023 AND VI 180 AND IP 23


Results: 11
    1
    2
    3
    4
    5
    6
    7

    The small molecule fibroblast growth factor receptor inhibitor infigratinib exerts anti‐inflammatory effects and remyelination in a model of multiple sclerosis.

    Published in:
    British Journal of Pharmacology, 2023, v. 180, n. 23, p. 2989, doi. 10.1111/bph.16186
    By:
    • Rajendran, Ranjithkumar;
    • Rajendran, Vinothkumar;
    • Böttiger, Gregor;
    • Stadelmann, Christine;
    • Shirvanchi, Kian;
    • von Au, Laureen;
    • Bhushan, Sudhanshu;
    • Wallendszus, Natascha;
    • Schunin, Darja;
    • Westbrock, Victor;
    • Liebisch, Gerhard;
    • Ergün, Süleyman;
    • Karnati, Srikanth;
    • Berghoff, Martin
    Publication type:
    Article
    8
    9
    10
    11

    Issue Information.

    Published in:
    British Journal of Pharmacology, 2023, v. 180, n. 23, p. 2935, doi. 10.1111/bph.15891
    Publication type:
    Article